Clinical trial

Esketamine and Propofol for Children With Autism Spectrum Disorder Undergoing Colonoscopy

The Second Hospital of Nanjing Medical UniversityCompletedStarted Jul 20, 202346 enrolledChinaNCT05951465

Abstract

The purpose of this study is to examine the dose-response relationship of esketamine in combination with propofol for children with Autism Spectrum Disorder undering colonoscopy.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Ketamine

Keywords

colonoscopyanaesthesiaautism spectrum disorderpropofolesketamineAutism Spectrum Disorder

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleMDMA

Chemsex drugs: More than ghb, mephedrone and methamphetamine?

Ramos J, Dolengevich H, Romerosa M +1

Europe PMC2021

ArticleKetamine

Midazolam-Ketamine (MK) Versus Propofol-Ketamine (PK) for Pediatric Burn Patients Undergoing Dressing Changes: A Non-Randomized Cross-Over Clinical Trial.

Guellim S, Hamada HB, Bouji N +4

Europe PMC2025

ArticleKetamine

Efficacy and safety comparison of esketamine-propofol with nalbuphine-propofol for upper gastrointestinal endoscopy in children: a multi-center randomized controlled trial.

Zheng X, Huang J, Wei S +6

Europe PMC2023